SCHEMBL2508288

SCHEMBL2508288

C(=C(\c1ccccc1)c1ccc2ccccc2c1)\c1ccc(-c2ccc(/C=C(\c3ccccc3)c3ccc4ccccc4c3)c3ccccc23)c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
EGFR P00533 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
JAK1 P23458 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP1B1 Q16678 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2508290 1.00 CES2 (0.40) CES2CES1KDM4EMEN1ALDH1A1
SCHEMBL2510220 0.85 CYP19A1 (0.42) MEN1ALDH1A1MAPTKMT2AMAPK1
SCHEMBL2499605 0.81 RAB9A (0.38) MEN1MAPTKMT2ATP53HPGD
SCHEMBL2499606 0.81 RAB9A (0.38) MEN1MAPTKMT2ATP53HPGD
SCHEMBL19784597 0.80 ESR1 (0.36) MEN1MAPTKMT2AMAPK1SMN1; SMN2
SCHEMBL6761889 0.77 CYP19A1 (0.39) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL2506548 0.77 NR4A1 (0.43) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL2506549 0.77 NR4A1 (0.43) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL2509405 0.76 PTGS2 (0.42) CES2CES1KDM4EMEN1ALDH1A1
SCHEMBL10324275 0.75 F2 (0.38) CES2CES1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110241558-A1 Light-Emitting Device and Driving Method Thereof SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2011-10-06 US disclosed
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE GLB1, CYP1A1, CRY1 CES2 1211/4885CES1 1023/4885KDM4E 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.